MoneyWorks4Me

The sales slipped to Rs. 678.30 millions for the June 2026 quarter as against Rs. 790.43 millions during the year-ago period.A big decline of -37.22% was reported for the quarter ended June 2026 to Rs. 32.39  millions from Rs. 51.59 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 101.02 millions from 118.46 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 678.30 790.43 -14.19 678.30 790.43 -14.19 3009.90 3333.71 -9.71
Other Income 4.56 10.09 -54.81 4.56 10.09 -54.81 14.21 39.46 -63.99
PBIDT 101.02 118.46 -14.72 101.02 118.46 -14.72 418.89 481.77 -13.05
Interest 18.13 17.33 4.62 18.13 17.33 4.62 60.34 78.81 -23.44
PBDT 82.89 101.13 -18.04 82.89 101.13 -18.04 358.55 402.96 -11.02
Depreciation 30.12 26.34 14.35 30.12 26.34 14.35 106.64 102.56 3.98
PBT 52.77 74.79 -29.44 52.77 74.79 -29.44 251.91 300.40 -16.14
TAX 20.38 23.20 -12.16 20.38 23.20 -12.16 74.14 86.70 -14.49
Deferred Tax 4.38 0.70 525.71 4.38 0.70 525.71 20.92 -1.41 -1583.69
PAT 32.39 51.59 -37.22 32.39 51.59 -37.22 177.77 213.70 -16.81
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 14.89 14.99 -0.63 14.89 14.99 -0.63 13.92 14.45 -3.70

Haleos Labs Share Price

1454.05 14.95 (1.04%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: